Ocera to Present at the 16th Annual Needham Healthcare Conference
March 27 2017 - 4:05PM
Ocera Therapeutics, Inc. (NASDAQ:OCRX), a clinical stage
biopharmaceutical company focused on acute and chronic orphan liver
diseases, today announced that Michael Byrnes, Chief Financial
Officer, will be presenting at the upcoming 16th Annual Needham
Healthcare Conference being held April 4-5, 2017 at The Westin
Grand Central in New York, New York. Ocera’s presentation will take
place on April 4, 2017 at 4:20 PM Eastern Time.
A live audio webcast of the presentation will be available in
the "Investors" section of Ocera's website, www.ocerainc.com. A
replay of the presentation will be available for 90 days following
the conference for those unable to listen live.
About Ocera
Ocera Therapeutics, Inc. is a clinical stage biopharmaceutical
company focused on the development and commercialization of OCR-002
(ornithine phenylacetate) in both intravenous and oral
formulations. OCR-002 is an ammonia scavenger and has been granted
orphan drug designation and Fast Track status by the U.S. Food and
Drug Administration (FDA) for the treatment of hyperammonemia and
resultant hepatic encephalopathy in patients with acute liver
failure and acute-on-chronic liver disease. For additional
information, please see www.ocerainc.com.
Contact:Susan SharpeOcera Therapeutics,
Inc.contact@ocerainc.com919-328-1109
Ocera Therapeutics, Inc. (NASDAQ:OCRX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Ocera Therapeutics, Inc. (NASDAQ:OCRX)
Historical Stock Chart
From Sep 2023 to Sep 2024